VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Monolithic Power Systems, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Monolithic Power Systems, Inc.
MPWR · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Monolithic Power Systems, Inc.'s moat claims, evidence, and risks.
View MPWR analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 67 / 100 for Monolithic Power Systems, Inc.).
- Segment focus: Monolithic Power Systems, Inc. has 6 segments (32.5% in Enterprise Data); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Monolithic Power Systems, Inc. has 4 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Monolithic Power Systems, Inc.
Enterprise Data
Power management ICs and power modules for enterprise/data center servers (CPU/GPU/AI accelerators) and cloud/on-prem compute platforms
Global
OEMs/ODMs and cloud platform designers
Fabless component supplier (power semiconductors)
32.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Monolithic Power Systems, Inc. strengths
Sanofi strengths
Segment mix
Monolithic Power Systems, Inc. segments
Full profile >Enterprise Data
Oligopoly
Storage and Computing
Competitive
Automotive
Oligopoly
Communications
Oligopoly
Consumer
Competitive
Industrial
Oligopoly
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.